Horizon Pharma plc buy BiotechBee
Start price
07.09.22
/
70%
€61.22
Target price
31.12.25
€100.00
Performance (%)
73.41%
End price
14.12.22
€106.16
Summary
This prediction ended on 14.12.22 with a price of €106.16. The BUY prediction by BiotechBee for Horizon Pharma plc saw massive gains of 73.41%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Horizon Pharma plc | - | - | - |
| iShares Core DAX® | -0.205% | 2.528% | 16.157% |
| iShares Nasdaq 100 | 1.613% | 4.733% | 30.626% |
| iShares Nikkei 225® | -0.740% | 0.396% | 9.039% |
| iShares S&P 500 | 0.267% | 2.720% | 26.333% |
According to BiotechBee what are the pros and cons of Horizon Pharma plc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Horizon Pharma plc diskutieren
Buy mit Kursziel 100,0